Preoperative imaging evaluation of interventional therapy for patients with symptomatic intracranial

来源 :首届中国神经介入大会 | 被引量 : 0次 | 上传用户:gwq939
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective To investigate the value of comprehensive preoperative imaging evaluation in determining indication of intervention for patients with symptomatic intracranial artery stenosis.Methods DSA, high-resolution MRI of plaque and computed tomography perfusion(CTP)or perfusion weighted imaging(PWI)were performed in 26 patients with symptomatic intracranial artery stenosis and the intracranial artery cavity.artery wall and cerebral perfusion were evaluated.For patients with atherosclerotic plaque, the plaque characterization was analyzed according to hish-resolution MRI findings, and intervention Was used for those with unstable plaque.However.medicine Was used for patients with arteriti.All patients were followed up after therapy.Results Combining with DSA, the stenosis in 18 cases Was thougIlt to be associated with athemsclerotic plaque, which showed eccentric stenosis with mild or no enhancement on MRI ; 13 of them had symptomatic unstable plaques, 1 case showed stable plaque but cerebral perfusion damaged severely, all of them were treated with interventional therapy ; the other 4 cases had stable plaques and treated with medicine.The stenosis in 8 patients.which showed concentric hypertrophy of lOCal endangium on MRI, was caused by arteritis and treated with medicine.No ischemic events OCCUlTed during the following 1_8 months[average(5.2 ± 3.1)months]after therapy.Conclusion Comprehensive preoperative imaging evaluation for patients with symptomatic intracranial artery stenosis is of great value in guiding the therapy.
其他文献
会议
会议
会议
会议
会议
  Purpose: Genetic variants in apolipoprotein A5 (APOA5) have been shown to be associated with triglyceride (TG) levels and to influence lipid responses to fi
会议
会议
会议
  目的:探讨覆膜支架治疗颅内动脉瘤的适应症和效果.方法:5年内用9枚Jostent覆膜支架选择性的治疗颅内动脉瘤病人9例,年龄28~65岁(平均46岁),其中,颈内动脉海绵窦段宽颈动脉瘤
会议